Average use of statins in FIELD and assumed effects on subsequent LDL cholesterol.

*Derived from meta-analysis of short-term randomized trials of statins [24].
†Calculated from the percentage reduction in LDL cholesterol applied to the average prior LDL cholesterol level in each treatment group for those patients who subsequently started lipid-lowering therapy.
‡93% of patients who started other lipid-lowering treatment took statins.
§Based on a weighted average of LDL change for individual statins.
FIELD = Fenofibrate Intervention and Event Lowering in Diabetes; LDL = low-density lipoprotein.